Anaphylactic Shock
Anaphylactic Shock Disease Injury Lawsuits
Anaphylactic Shock Can Be Life Threatening. Anaphylactic shock, also known as anaphylaxis arises when a person ingests or comes into contact with a substance to which they are severely allergic. Prescription medicines, food, insect stings and latex commonly cause anaphylactic shock. This reaction can be life threatening and … [Read more...] about Anaphylactic Shock Disease Injury Lawsuits
FDA Issues New Xolair Warning
FDA Issued Warning About Asthma Drug Xolair. Citing reports of severe, potentially fatal allergic reactions, the U.S. Food and Drug Administration (FDA) has issued a new warning about omalizumab, an asthma drug marketed by Genentech as Xolair. The agency has requested a “black box” warning be added to the product’s label reflecting … [Read more...] about FDA Issues New Xolair Warning
Xolair Delayed-Onset Anaphylaxis Risk
Xolair May Be Linked To Delayed-Onset Anaphylaxis. Omalizumab subcutaneous injection (Xolair, made by Genentech, Inc) may be linked to life-threatening anaphylaxis, according to a warning from the US Food and Drug Administration (FDA). Although most cases (71%) have occurred within 2 hours of omalizumab injection, some (13%) … [Read more...] about Xolair Delayed-Onset Anaphylaxis Risk
FDA Orders Xolair Warnings
FDA Ordered Genentech Inc. To Add Warnings For Xolair. The U.S. Food and Drug Administration ordered Genentech Inc. to add a boxed warning to its asthmatic drug marketed as Xolair. The FDA said the boxed warning should emphasize Xolair (omalizumab) might cause anaphylaxis, including trouble breathing, chest tightness, dizziness, … [Read more...] about FDA Orders Xolair Warnings
FDA orders stronger asthma drug warning
Government Ordered Label Warnings For An Asthma Drug. The government ordered stronger label warnings for an injected asthma medication Wednesday because of reports some patients taking the drug, marketed as Xolair, had suffered a delayed and potentially life-threatening reaction known as anaphylaxis. A patient experiencing … [Read more...] about FDA orders stronger asthma drug warning
